Page last updated: 2024-12-07

5'-(4-fluorosulfonylbenzoyl)adenosine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

5'-(4-fluorosulfonylbenzoyl)adenosine: affinity label of the inhibitory DPNH site of bovine liver dehydrogenase; adenosylhomocysteinase antagonist; structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID133128
SCHEMBL ID19666771
MeSH IDM0056883

Synonyms (24)

Synonym
5'-(4-fluorosulfonylbenzoyl)adenosine
5'-p-fluorosulfonylbenzoyladenosine
5'-(4-(fluorosulfonyl)benzoyl)adenosine
5'-(para-(fluorosulfonyl)benzoyl)adenosine
p-fluorosulfonylbenzoyl-5'-adenosine
5'-(para-(fluorosulfonyl)benzoyl)adenosine hydrochloride
5'-(4-fluorosulfonylbenzoyl)adenosine hydrochloride
5-fsba
78859-42-4
[(2r,3s,4r,5r)-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methyl 4-fluorosulfonylbenzoate hydrochloride
A840561
4-fluorosulfonylbenzoic acid [(2r,3s,4r,5r)-5-(6-aminopurin-9-yl)-3,4-dihydroxy-2-oxolanyl]methyl ester hydrochloride
5'-(4-fluorosulfonylbenzoyl)adenosine hydrochl oride
fsba
adenosine-5'-(4-fluorosulfonylbenzoate) hydrochloride
AKOS027381458
ZUHVYHQVJYIHPN-KHXPSBENSA-N
5'-p-fluorosulfonyl-benzoyladenosine hydrochloride
SCHEMBL19666771
((2r,3s,4r,5r)-5-(6-amino-9h-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl 4-(fluorosulfonyl)benzoate hydrochloride
((2r,3s,4r,5r)-5-(6-amino-9h-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl4-(fluorosulfonyl)benzoatehydrochloride
9-{5-o-[4-(fluorosulfonyl)benzoyl]pentofuranosyl}-9h-purin-6-amine--hydrogen chloride (1/1)
DTXSID201000089
[(2r,3s,4r,5r)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl 4-fluorosulfonylbenzoate;hydrochloride
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (212)

TimeframeStudies, This Drug (%)All Drugs %
pre-1990114 (53.77)18.7374
1990's80 (37.74)18.2507
2000's15 (7.08)29.6817
2010's3 (1.42)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 8.64

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index8.64 (24.57)
Research Supply Index5.38 (2.92)
Research Growth Index4.02 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (8.64)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (0.47%)5.53%
Reviews4 (1.86%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other210 (97.67%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]